BRIDGEWAY CAPITAL MANAGEMENT, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$118,000
-86.2%
33,800
-60.1%
0.00%
-75.0%
Q3 2018$854,000
+54.7%
84,700
+11.2%
0.01%
+33.3%
Q2 2018$552,000
+20.0%
76,2000.0%0.01%
+20.0%
Q1 2018$460,000
+200.7%
76,200
+486.2%
0.01%
+150.0%
Q3 2016$153,000
-8.9%
13,0000.0%0.00%
-33.3%
Q2 2016$168,000
-19.2%
13,0000.0%0.00%0.0%
Q1 2016$208,000
-44.1%
13,0000.0%0.00%
-57.1%
Q4 2015$372,000
-4.9%
13,000
-5.5%
0.01%
-12.5%
Q3 2015$391,000
-36.0%
13,750
-19.1%
0.01%
-33.3%
Q2 2015$611,000
+29.7%
17,000
+109.9%
0.01%
+20.0%
Q1 2015$471,000
+57.5%
8,100
+14.1%
0.01%
+42.9%
Q4 2014$299,0007,1000.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders